UK markets close in 10 minutes

Inari Medical, Inc. (NARI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
38.84-0.65 (-1.65%)
As of 11:19AM EDT. Market open.

Inari Medical, Inc.

6001 Oak Canyon
Suite 100
Irvine, CA 92618
United States
877 923 4747
https://www.inarimedical.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees1,300

Key executives

NameTitlePayExercisedYear born
Mr. Andrew J. HykesCEO, President & Director1.54MN/A1974
Mr. Mitchell C. HillChief Financial Officer864.63k4.78M1959
Dr. Thomas M. Tu M.D.Chief Medical Officer865.63k1.17M1973
Mr. Paul A. KoehnSenior Vice President of OperationsN/AN/A1963
Mr. Kevin StrangeSenior Vice President of Finance, Accounting, Strategy & Business DevelopmentN/AN/AN/A
Mr. John Hsu C.F.A.Vice President of Investor RelationsN/AN/AN/A
Ms. Angela AhmadGeneral Counsel & SecretaryN/AN/AN/A
Mr. Eric KhairySenior Vice President of MarketingN/AN/AN/A
Mr. John R. BorrellSenior Vice President of SalesN/AN/A1967
Ms. Tara DunnSenior VP & GM of LimFlowN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Corporate governance

Inari Medical, Inc.’s ISS governance QualityScore as of 1 April 2024 is 5. The pillar scores are Audit: 2; Board: 5; Shareholder rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.